Russian COVID-19 Treatment Drug May Get Approved By End Of 2022 - Gamaleya
Mohammad Ali (@ChaudhryMAli88) Published November 21, 2021 | 10:20 PM
MOSCOW (UrduPoint News / Sputnik - 21st November, 2021) The Russian Gamaleya research center has developed the chemical compounds to create a drug to treat COVID-19 and expects to get it approved by the end of next year after clinical trials, Denis Logunov, the center's deputy head, said on Sunday.
Currently, the development of the drug is at an early stage and trials on animals are still required, Logunov said at a meeting with Russian President Vladimir Putin.
"At the moment we have carried out an initial screening, and we have compounds... that are hits, leading compounds that will be optimized and tested in experiments on animals," Logunov explained.
Creating COVID-19 treatment drug takes more time than creating a drug based on monoclonal antibodies, Logunov added. He expressed hope that the drug will be registered by the end of 2022 after successful animal and clinical trials.
Related Topics
Recent Stories
Tennis: ATP Barcelona Open results - 1st update
Swiatek's perfect 10 in Stuttgart as Vondrousova stuns Sabalenka
Arandu's roads closed due to flooding
Oil tanker catches fire in Islamabad’s Blue Area
Pakistan committed to ensure safety of foreign nationals: FO
Tennis: WTA Stuttgart results - 1st update
Four passengers injured as train hit an empty vehicle
Over- speeding bus crushed to death two bike riders
Turkey's Freedom Flotilla ready to set sail for Gaza
French teen dies from heart failure after knife attack near school
Iranians appear unfazed by Isfahan blasts
UAF celebrates Int'l Chinese Language Day
More Stories From World
-
Togo lawmakers approve contested political reform
3 hours ago -
NATO must choose 'whether we indeed are allies': Zelensky
3 hours ago -
US House to vote on Ukraine, Israel, Taiwan aid package
3 hours ago -
Calls for calm after reported Israeli strike on Iran
3 hours ago -
IMF calls on EU to deepen single market integration to boost growth
3 hours ago -
Second Ecuadoran mayor killed ahead of anti-crime referendum: police
3 hours ago
-
Oil, gas drilling blocked in Alaska wilds as Biden seeks green cred
4 hours ago -
Man sets self on fire outside Trump trial
4 hours ago -
Turkey's Freedom Flotilla ready to set sail for Gaza
6 hours ago -
French teen dies from heart failure after knife attack near school
6 hours ago -
Iranians appear unfazed by Isfahan blasts
6 hours ago -
Ecuador mayor killed ahead of anti-crime referendum: police
6 hours ago